Bibliography

Alafuzoff, I., et al. 1987. Histopathological criteria for progressive dementia disorders: Clinical pathological correlation and classification by multivariate data analysis. Acta Neuropathologica 74: 209-25.

Albert, M. T., R. G. Feldman, and A. L. Willis. 1974. The subcortical dementia of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psy­chiatry 37: 121-50.

Albert, M. T., et al. 1984. CT density numbers in patients with senile dementia of the Alzheimer type. Archives ofNeurology 41: 1264—9.

Bartus, R. T., et al. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-17.

Beach, Thomas G. 1987. The history of Alzheimer’s dis­ease: The debates. Journal of the History of Medicine and Allied Sciences 42: 327-49.

Blessed, G., B. E. Tomlinson, and M. Roth. 1968. The association between quantitative measures of demen­tia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 114: 797-811.

Brodie, J. A. 1982. An epidemiologist views senile demen­tia facts and fragments. American Journal of Epide­miology 115: 115—62.

Christie, J. E., et al. 1981. Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer pre­senile dementia. British Journal of Psychiatry 138: 46-50.

Cohen, E. L., and R. J. Wurtman. 1976. Brain acetylcho­line: Control by dietary choline. Science 191: 561-2.

Cook, R. H., et al. 1979. Studies in aging of the brain: ΓV. Familial Alzheimer disease: relation of transmissible dementia, aneuploidy, and microtubular defects. Neu­rology 29: 1404—12.

Coyle, J. T., D. Price, and M. R. DeLong. 1983. Alzheimer’s disease: A disorder of central cholinergic innervation. Science 219: 1184—9.

Cummings, J. L., and D. F. Benson. 1983. Dementia: A clinical approach. London.

Devanand₁ D.

Eisdorfer, C., and D. Cohen. 1981. Management of the patient and family coping with dementing illness. Journal of Family Practice 12: 831—7.

Folstein, M. F., S. E. Folstein, and P. R. McHugh. 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12: 189-98.

Fox, T. H., J. L. Topel, and M. S. Huckman. 1975. Use of computerized tomography in senile dementia. Journal ofNeurology, Neurosurgery andPsychiatry 38:948-53.

Gustafson, L., and L. Nilsson. 1982. Differential diagnosis of presenile dementia on clinical grounds. Acta Psychi- atrica Scandinavica 65: 194—209.

Harner, R. N. 1975. EEG evaluation of the patient with dementia. In Psychiatric aspects of neurologic disease, ed. D. F. Benson and D. Blumer, 63—82. New York.

Haxby, J. V., et al. 1986. Neocortical metabolic abnormali­ties precede nonmemory cognitive defects in early Alzheimer’s-type dementia. Archives ofNeurology 43: 882-5.

Hersch, E. L. 1979. Development and application of the extended scale for dementia. Journal OftheAmerican Geriatrics Society 27: 348—54.

Heston, L. L., and A. R. Masri. 1966. The genetics of Alzheimer’s disease: Associations with hematologic malignancy and Down’s syndrome. Archives of Gen­eral Psychiatry 34: 976—81.

Hughes, C. P., et al. 1982. A new clinical scale for the staging of dementia. British Journal of Psychiatry 140: 566-72.

Johnson, K. A., et al. 1987. Comparison of magnetic reso­nance and roentgen ray computed tomography in de­mentia. Archives of Neurology 44: 1075-80.

1988. Single photon emission computed tomography in Alzheimer’s disease: Abnormal iofetamine I¹²³ uptake reflects dementia severity. Archives of Neurology 45: 392-6.

Katzman, R. 1976. The prevalence in malignancy of Alzheimer’s disease: A major killer (editorial).

1986. Alzheimer’s disease. New England Journal of Medicine 314: 964-73.

Kay, D. W K., P. Beamish, and M. Roth. 1964. Old age mental disorders in Newcastle-upon-Tyne. British Journal OfPsychiatry 110:146—8.

Khachaturian, Z. S. 1985. Diagnosis of Alzheimer’s dis­ease. Archives ofNeurology 42: 1097-105.

Kokmen, E. 1984. Dementia: Alzheimer type. Mayo Clinic Proceedings 59: 35-42.

Kral, B. A. 1962. Forgetfulness: Benign and malignant. CanadianMedicalAssociationJournal. 86: 257—60.

Markesbery, W. R., et al. 1981. Instrumental neutron acti­vation analysis of brain aluminum in Alzheimer’s dis­ease and aging. Annals ofNeurology 10: 511—16.

Marttila, R. J., and U. K. Rinne. 1976. Dementia in Parkin­son’s Disease. Acta Neurologica Scandinavica 54: 431-41.

Mayeux, R., Y. Stem, and S. Spanton. 1985. Clinical het­erogeneity in patients with dementia of the Alz­heimer type: Evidence for subgroups. Neurology 35: 453-61.

McKhann, G., et al. 1984. Clinical diagnosis of Alz­heimer’s disease: Report of the NINCDS-ADRDA ADRDA Work Group under the auspices of Depart­ment of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939—44.

Morris, J. C., et al. 1988. Consortium to establish a regis­try for Alzheimer’s disease. Psychopharmacology Bul­letin 24: 641—52.

Mundy-Castle, A. C., et al. 1953. The electroencephalo­gram in the senile psychosis. Electroencephalography and Clinical Neurophysiology 6: 245-52.

Nuwer, M. R. 1988. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. Journal of Clinical Neurophysiology 5: 45-85.

Rabins, Peter V. 1988. Science and medicine in the spot­light: Alzheimer’s disease as an example. Perspectives in Biology and Medicine 31: 161-9.

Reisberg, Barry. 1983. Alzheimer’s disease. New York and London.

Reisberg, B., et al. 1982. The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia.

Reisberg, B., et al. 1983. The Brief Cognitive Rating Scale (BCRS): Findings in primary degenerative dementia. Psychopharmacology Bulletin 19: 47—50.

Reynolds, C. F., et al. 1983. Electroencephalographic sleep aging, and psychopathology: New data and state of art. Biological Psychiatry 18: 139—55.

Salzman, C., G. E. Kochansky, and R. I. Shader. 1972. Rating scales for geriatric psychopharmacology — a re­view. Psychopharmacology Bulletin 8: 3—50.

Schenk, N. K., B. Reisberg, and S. H. Ferris. 1982. An overview of current concepts of Alzheimer’s disease. American Journal OfPsychiatry 139: 165—73.

Seltzer, B., and I. Sherwin. 1983. A comparison of clinical features in early and late-onset primary degenerative dementia: One entity or two? Archives of Neurology 40: 143-6.

Sharp, P., et al. 1986. Application of iodine-I¹²³ labeled isopropylamphetamine imaging to the study of demen­tia. Journal of Nuclear Medicine 27: 761—8.

Sojdel-Sulkhowska, E. M., and C. A. Marotta. 1984. Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease—inhibitor complex. Science 225: 947-9.

Spor, J. E., and R. Gerner. 1982. Does the dexamethasone suppression test distinguish dementia from depres­sion? American Journal of Psychiatry 139: 238-40.

St. George-Hyslop, P. H., et al. 1987. The genetic defect causing familial Alzheimer’s disease maps on chromo­some 21. Science 235: 885—90.

Stem, Y., M. Sano, and R. Mayeux. 1988. Long-term ad­ministration of oral physostigmine in Alzheimer’s dis­ease. Neurology 38: 1837—41.

Summers, W. K., et al. 1986. Oral tetrahydroamino­acridine in long-term treatment of senile dementia Alzheimer’s disease. New England Journal of Medi­cine 315:1241—5.

Terry, R. D., et al. 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. An­nals of Neurology 10: 184—92.

Thai, L. J., et al. 1983. Oral physostigmine and lecithin improve memory in Alzheimer’s disease.

Tierney, M. C., et al. 1988. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: A Clinicopathologic study of 57 cases. Neurology 38: 359—64.

Tomilson, D. E., G. Blessed, and M. Roth. 1968. Observa­tions on the brains of non-demented old people. Jour­nal of the Neurological Sciences 7: 331—56.

1970. Observations on the brains of demented old peo­ple. Journal of the Neurological Sciences 11: 205—32. Vannoy, John F., and James A. Greene. 1989. Alzheimer’s disease: A brief history. Journal of the Tennessee Medi­cal Association 82: 15—17.

Visser, S. L., et al. 1976. Visual evoked response in senile and presenile dementia. Electroencephalography and Clinical Neurophysiology 40: 385-92.

Volicer L., and L. R. Herz. 1985. Pharmacologic manage­ment of Alzheimer-type dementia. American Family Physician 32: 123—8.

Watts, H., P. G. E. Kennedy, and M. Thomas. 1981. The significance of antineuronal antibodies in Alzheimer’s disease. Journal OfNeuroimmunology 1: 107-16.

Wells, C. E. 1977. Dementia. Philadelphia.

1979. Pseudodementia. American Journal of Psychiatry 136: 895-900.

Wettstein, A., and R. Spiegel. 1984. Clinical trials with the cholinergic drug RS86 in Alzheimer’s disease (AD) and senile dementia of the Alzheimer’s type (SDAT). Psychopharmacology 84: 572—3.

Wisniewski, H. M. 1978. Possible viral etiology of neurofibrillary changes and neuritic plagues. In Alzheimer’s disease: senile dementia and related disor­ders, ed. R. Katzman, R. D. Terry, and K. L. Beck, 355-8. New York.

1989. Alzheimer’s disease and related disorders. New York.

Wurtman, R. J., M, J. Hirsch₁ and J. Growdon. 1977. Leci­thin consumption raises serum free-choline levels. Lancet 2: 68—9.

VIII.